share_log

Marpai | 8-K: MARPAI reports FOURTH QUARTER AND FULL YEAR 2023 financial results

Marpai | 8-K: Current report

Marpai | 8-K：重大事件
SEC announcement ·  03/27 05:21
牛牛AI助理已提取核心訊息
On March 26, 2024, Marpai, Inc., a Third-Party Administration company operating in the healthcare sector, released its financial results for the fourth quarter and the full year of 2023. The report highlighted a year-over-year improvement in net revenues, gross profit, and a reduction in operating loss and net loss for the quarter. Specifically, Q4 net revenues increased by 14% to $8.7 million, gross profit rose by 6.5% to $3.0 million, and operating loss and net loss improved by 42.3% and 41.1%, respectively. For the full year, net revenues saw a significant increase of 52.6% to $37.2 million, and gross profit surged by 79.2% to $12.9 million. However, operating expenses and net loss also increased compared to the previous year. The company attributes part of its financial improvement to the acquisition of Maestro Health and corrective actions taken in Q4. Marpai's CEO, Damien Lamendola, emphasized the company's commitment to reducing costs for clients and improving care quality. A webcast to discuss these results is scheduled for March 27, 2024.
On March 26, 2024, Marpai, Inc., a Third-Party Administration company operating in the healthcare sector, released its financial results for the fourth quarter and the full year of 2023. The report highlighted a year-over-year improvement in net revenues, gross profit, and a reduction in operating loss and net loss for the quarter. Specifically, Q4 net revenues increased by 14% to $8.7 million, gross profit rose by 6.5% to $3.0 million, and operating loss and net loss improved by 42.3% and 41.1%, respectively. For the full year, net revenues saw a significant increase of 52.6% to $37.2 million, and gross profit surged by 79.2% to $12.9 million. However, operating expenses and net loss also increased compared to the previous year. The company attributes part of its financial improvement to the acquisition of Maestro Health and corrective actions taken in Q4. Marpai's CEO, Damien Lamendola, emphasized the company's commitment to reducing costs for clients and improving care quality. A webcast to discuss these results is scheduled for March 27, 2024.
2024年3月26日，在醫療保健領域運營的第三方管理公司Marpai, Inc. 發佈了第四季度和2023年全年的財務業績。該報告強調了本季度淨收入、毛利同比增長以及營業虧損和淨虧損的減少。具體而言，第四季度淨收入增長了14％，達到870萬美元，毛利增長了6.5％，達到300萬美元，營業虧損和淨虧損分別增長了42.3％和41.1％。全年淨收入大幅增長52.6％，達到3,720萬美元，毛利增長79.2％，至1,290萬美元。但是，與去年相比，運營費用和淨虧損也有所增加。該公司將其財務改善的一部分歸因於對Maestro Health的收購以及第四季度採取的糾正措施。Marpai首席執行官達米安·拉門多拉強調了該公司對降低客戶成本和提高護理質量的承諾。討論這些結果的網絡直播定於2024年3月27日舉行。
2024年3月26日，在醫療保健領域運營的第三方管理公司Marpai, Inc. 發佈了第四季度和2023年全年的財務業績。該報告強調了本季度淨收入、毛利同比增長以及營業虧損和淨虧損的減少。具體而言，第四季度淨收入增長了14％，達到870萬美元，毛利增長了6.5％，達到300萬美元，營業虧損和淨虧損分別增長了42.3％和41.1％。全年淨收入大幅增長52.6％，達到3,720萬美元，毛利增長79.2％，至1,290萬美元。但是，與去年相比，運營費用和淨虧損也有所增加。該公司將其財務改善的一部分歸因於對Maestro Health的收購以及第四季度採取的糾正措施。Marpai首席執行官達米安·拉門多拉強調了該公司對降低客戶成本和提高護理質量的承諾。討論這些結果的網絡直播定於2024年3月27日舉行。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。